CollPlant Biotechnologies Ltd.
CLGN
$2.07
-$0.07-3.39%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 515.00K | 650.00K | 689.00K | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 515.00K | 650.00K | 689.00K | |
| Cost of Revenue | -- | 1.63M | 2.13M | 2.13M | |
| Gross Profit | -- | -1.11M | -1.48M | -1.44M | |
| SG&A Expenses | -- | 5.63M | 5.78M | 6.05M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 17.77M | 19.00M | 19.09M | |
| Operating Income | -- | -17.25M | -18.35M | -18.41M | |
| Income Before Tax | -- | -16.61M | -17.42M | -17.47M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -16.61 | -17.42 | -17.47 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -16.61M | -17.42M | -17.47M | |
| EBIT | -- | -17.25M | -18.35M | -18.41M | |
| EBITDA | -- | -16.21M | -17.27M | -17.31M | |
| EPS Basic | -- | -1.45 | -1.52 | -1.53 | |
| Normalized Basic EPS | -- | -0.44 | -0.49 | -0.49 | |
| EPS Diluted | -- | -1.45 | -1.52 | -1.53 | |
| Normalized Diluted EPS | -- | -0.44 | -0.49 | -0.49 | |
| Average Basic Shares Outstanding | -- | 45.82M | 45.82M | 45.80M | |
| Average Diluted Shares Outstanding | -- | 45.82M | 45.82M | 45.80M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |